v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 27, 2025
Jun. 28, 2024
Jun. 27, 2025
Jun. 28, 2024
Dec. 29, 2023
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents     $ 1.7 $ (2.2)  
Net Income (Loss) $ 2.4 $ (43.3)      
Depreciation and amortization     44.8 67.2  
Deferred income taxes     (6.5) 16.3  
(Amortization) accretion expense on debt premium/discount and settlement obligation     3.4 (2.1)  
Other Noncash Income (Expense)     (13.7) (5.8)  
Increase (Decrease) in Accounts Receivable     14.1 18.6  
Increase (Decrease) in Inventories     (62.3) (161.6)  
Accounts payable     20.6 (11.5)  
Income taxes     15.9 (5.9)  
Increase (Decrease) in Other Operating Assets and Liabilities, Net     (46.7) 41.0  
Net Cash Provided by (Used in) Operating Activities     161.7 47.0  
Payments to Acquire Property, Plant, and Equipment     40.4 50.9  
Payments for (Proceeds from) Other Investing Activities     (0.7) (0.7)  
Net Cash Provided by (Used in) Investing Activities     (45.9) (27.6)  
Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security     2.0 4.4  
Net Cash Provided by (Used in) Financing Activities     (4.2) (4.6)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect     113.3 12.6  
Cash and cash equivalents 497.8 291.1 497.8 291.1  
Restricted Cash and Investments, Current 19.5 23.6 19.5 23.6  
Restricted Cash and Investments, Noncurrent 41.7 41.3 41.7 41.3  
Cash Flows From Operating Activities:          
Net Income (Loss) 2.4 (43.3)      
Adjustments to reconcile net cash from operating activities:          
Depreciation and amortization     44.8 67.2  
Deferred income taxes     (6.5) 16.3  
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 0.5 0.0 6.7 0.0  
Other non-cash items     13.7 5.8  
Changes in assets and liabilities:          
Accounts receivable, net     (14.1) (18.6)  
Inventories     62.3 161.6  
Accounts payable     20.6 (11.5)  
Income taxes     15.9 (5.9)  
Acthar Gel-Related Litigation Settlement liability     (21.3) (21.4)  
Other     46.7 (41.0)  
Net Cash Provided by (Used in) Operating Activities     161.7 47.0  
Cash Flows From Investing Activities:          
Capital expenditures     (40.4) (50.9)  
Proceeds from Sale of Restricted Investments     0.0 22.6  
Payments related to divestiture (Note 3)     (6.2) 0.0  
Other     0.7 0.7  
Net Cash From Investing Activities     (45.9) (27.6)  
Cash Flows From Financing Activities:          
Repayment of debt     (2.0) (4.4)  
Repurchase of shares     (1.9) 0.0  
Net Cash Provided From Financing Activities     (4.2) (4.6)  
Net change in cash, cash equivalents and restricted cash, including cash classified within assets held for sale     113.3 12.6  
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance 559.0 356.0 559.0 356.0 $ 343.4
Cash and cash equivalents, end of period 497.8 291.1 497.8 291.1  
Other     (0.3) (0.2)  
Specialty Brands          
Depreciation and amortization 12.2 21.5 24.3 43.9  
Adjustments to reconcile net cash from operating activities:          
Depreciation and amortization 12.2 21.5 24.3 43.9  
Specialty Generics          
Depreciation and amortization 9.8 10.5 19.6 22.7  
Adjustments to reconcile net cash from operating activities:          
Depreciation and amortization 9.8 10.5 19.6 22.7  
Retained Earnings (Deficit)          
Net Income (Loss) 2.4 (43.3) (25.3) (108.7)  
Cash Flows From Operating Activities:          
Net Income (Loss) 2.4 $ (43.3) (25.3) (108.7)  
Additional Paid-In Capital          
Share-based compensation 4.8   14.8 5.3  
Adjustments to reconcile net cash from operating activities:          
Share-based compensation $ 4.8   $ 14.8 $ 5.3